[PHARMA] QoQ Annualized Quarter Result on 30-Sep-2018 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Nov-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
30-Sep-2018 [#3]
Profit Trend
QoQ- 10.33%
YoY- 18.76%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 2,775,996 3,144,432 2,384,956 2,384,416 2,401,304 2,471,692 2,323,960 12.61%
PBT 85,448 120,972 70,220 77,706 81,354 114,828 73,064 11.03%
Tax -27,628 -42,380 -26,990 -26,160 -34,644 -44,472 -17,977 33.27%
NP 57,820 78,592 43,230 51,546 46,710 70,356 55,087 3.28%
-
NP to SH 57,796 78,468 42,468 50,708 45,960 70,344 53,823 4.87%
-
Tax Rate 32.33% 35.03% 38.44% 33.67% 42.58% 38.73% 24.60% -
Total Cost 2,718,176 3,065,840 2,341,726 2,332,869 2,354,594 2,401,336 2,268,873 12.83%
-
Net Worth 518,564 528,825 509,862 522,618 519,642 524,838 526,888 -1.05%
Dividend
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Div 44,299 62,521 41,621 48,535 46,767 51,964 49,314 -6.91%
Div Payout % 76.65% 79.68% 98.01% 95.71% 101.76% 73.87% 91.62% -
Equity
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Net Worth 518,564 528,825 509,862 522,618 519,642 524,838 526,888 -1.05%
NOSH 261,229 260,505 260,505 260,505 259,821 259,821 259,821 0.36%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin 2.08% 2.50% 1.81% 2.16% 1.95% 2.85% 2.37% -
ROE 11.15% 14.84% 8.33% 9.70% 8.84% 13.40% 10.22% -
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
RPS 1,065.29 1,207.05 916.82 917.05 924.21 951.31 895.38 12.31%
EPS 22.18 30.12 16.33 19.51 17.68 27.08 20.74 4.58%
DPS 17.00 24.00 16.00 18.67 18.00 20.00 19.00 -7.16%
NAPS 1.99 2.03 1.96 2.01 2.00 2.02 2.03 -1.32%
Adjusted Per Share Value based on latest NOSH - 260,505
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
RPS 192.61 218.17 165.48 165.44 166.61 171.50 161.25 12.61%
EPS 4.01 5.44 2.95 3.52 3.19 4.88 3.73 4.95%
DPS 3.07 4.34 2.89 3.37 3.24 3.61 3.42 -6.96%
NAPS 0.3598 0.3669 0.3538 0.3626 0.3605 0.3642 0.3656 -1.06%
Price Multiplier on Financial Quarter End Date
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Date 28/06/19 29/03/19 31/12/18 28/09/18 29/06/18 30/03/18 29/12/17 -
Price 2.84 2.27 2.78 2.89 2.88 4.28 4.60 -
P/RPS 0.27 0.19 0.30 0.32 0.31 0.45 0.51 -34.63%
P/EPS 12.80 7.54 17.03 14.82 16.28 15.81 22.18 -30.75%
EY 7.81 13.27 5.87 6.75 6.14 6.33 4.51 44.35%
DY 5.99 10.57 5.76 6.46 6.25 4.67 4.13 28.21%
P/NAPS 1.43 1.12 1.42 1.44 1.44 2.12 2.27 -26.57%
Price Multiplier on Announcement Date
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Date 23/08/19 16/05/19 21/02/19 19/11/18 17/08/18 16/05/18 27/02/18 -
Price 2.66 2.36 2.76 3.09 3.11 4.07 4.04 -
P/RPS 0.25 0.20 0.30 0.34 0.34 0.43 0.45 -32.49%
P/EPS 11.99 7.83 16.91 15.84 17.58 15.03 19.48 -27.70%
EY 8.34 12.76 5.92 6.31 5.69 6.65 5.13 38.38%
DY 6.39 10.17 5.80 6.04 5.79 4.91 4.70 22.79%
P/NAPS 1.34 1.16 1.41 1.54 1.56 2.01 1.99 -23.23%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment